OXIDATIVE STERSS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RELATION TO CHARACTERISTICS OF THE DEVELOPMENT, PROGRESSION AND COMPLICATIONS (Review and our own results)

Authors

DOI:

https://doi.org/10.21856/j-PEP.2012.3.16

Keywords:

oxidative stress, type 2 diabetes mellitus, cardiovascular complications, chronic inflammation

Abstract

Review is devoted to the role of oxidative stress in the pathogenesis of type 2 diabetes mellitus
and its vascular complications. We present multiple correlations of indicators that comprehensively
characterize oxidative stress, with classic and novel parameters of insulin resistance, dyslipidemia,
and chronic inflammation in patients with type 2 diabetes mellitus.

References

Giacco, F. Oxidative stress and diabetic complications [Text] / F. Giacco, M. Brownlee // Cir. Res. — 2010. — Vol. 107. — P. 1058–1070.

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes [Text] / J. L. Evans, I. D. Goldfine, B. A. Maddux, G. M. Grodsky // Endocrine Rev. — 2002. — Vol. 23, № 5. — P. 599–622.

Oxidative stress in the pathogenesis of diabetic neuropathy [Text] / A. M. Vincent, J.W. Russel, P. Low, E. L. Feldman // Endocrinol. Rev. — 2004. — Vol. 25, № 4. — P. 612–628.

Gerschman, R. Oxygen poisoning and X-irradiation: a mechanism in common [Text] / R. Gerschman, D. Gilbert, S.W. Nye // Science. —

— Vol. 119. — P. 623–626.

Sies, H. Oxidative stress: introductory remarks [Text] / H. Sies // Oxidative Stress / edited by Sies H. — New York: Academic, 1985. — P. 1–8.

Sies, H. Oxidative Stress: Oxidants and Antioxidants [Text] / H. Sies // London: Academic, 1991. — 72 p.

Sies, H. What is oxidative stress? [Text] / H. Sies // Oxidative Stress and Vascular Disease // edited by Keaney J. F., Jr. — Boston: Kluwer Academic, 2000. — P. 1–8.

Turrens, J. F. Mitochondrial formation of reactive oxygen species [Text] / J. F. Turrens. // J. Physiol. — 2003. — Vol. 552, Pt. 2. — P. 335–344.

Förstermann, U. Nitric oxide and oxidative stress in vascular disease [Text] / U. Förstermann // Pflugers Arch. — 2010. — Vol. 459, № 6. — P. 923–39.

Hayden, M. R. Intimal redox stress: Accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy [Text] / M. R. Hayden, S. C. Tyagi // Cardiovascular Diabetology. — 2002. — Vol. 1, № 3. — P. 1–27.

Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice [Text] / J. Schultz Johansen, A. K. Harris, D. J. Rychly, A. Ergul // Cardiovasc. Diabetol. — 2005. — Vol. 4, № 5. — P. 1–11.

Stocker, R. Role of oxidative modifications in atherosclerosis [Text] / R. Stocker, J. F. Keaney, Jr. // Physiol. Rev. — 2004. — Vol. 84. — P. 1381–1478.

Biomarkers of fruit and vegetable intake in human intervention studies: a systematic review [Text] / F. R. Baldrick, J. V. Woodside, J. S. Elborn [et al.] // Crit. Rev. Food Sci. Nutr. — 2011. — Vol. 51, № 9. — P. 795–815.

Tocotrienols: the lesser known form of natural vitamin E [Text] / V. Patel, C. Rink, S. Khanna, C. K. Sen // Indian J. Exp. Biol. — 2011. — Vol. 49, № 10. — P. 732–738.

Yuan, L. Glutathione in liver diseases and hepatotoxicity [Text] / L. Yuan, N. Kaplowitz // Mol. Aspects Med. — 2009. — Vol. 30, № 1–2. — P. 29–41.

Quinzii, C. M. Coenzyme Q and mitochondrial disease [Text] / C. M. Quinzii, M. Hirano // Dev. Disabil. Res. Rev. — 2010. — Vol. 16, № 2. — P. 183–188.

Lipoic acid — biological activity and therapeutic potential [Text] / A. Gorąca, H. Huk-Kolega, A. Piechota [et al.] // Pharmacol. Rep. — 2011. — Vol. 63, № 4. — P. 849–858.

Dröge, W. Free radicals in the physiological control of cell function [Text] / W. Dröge // Physiol. Rev. — 2002. — Vol. 82. — P. 47–95.

Finkel, T. Reactive oxygen species and signal transduction [Text] / T. Finkel // IUB-MB Life. — 2001. — Vol. 52. — P. 3–6.

Irani, K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling [Text] / K. Irani // Circ. Res. — 2000. — Vol. 87. — P. 179–183.

Free radicals and antioxidants in normal physiological functions and human disease [Text] / M. Valko, D. Leibfritz, J. Moncol [et al.] // Int. J. Biochem. Cell. Biol. — 2007. — Vol. 39. — P. 44–84.

Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology [Text] / K. K. Griendling, D. Sorescu, B. Lassegue, M. Ushio-Fukai // Arterioscler. Thromb. Vasc. Biol. — 2000. — Vol. 20. — P. 2175–2183.

Shelton, M. D. Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases [Text] / M. D. Shelton, J. J. Mieyal // Mol. Cells. — 2008. — Vol. 25. — P. 332–346.

Glutaredoxin modulates platelet-derived growth factor-dependent cell signaling by regulating the redox status of low molecular weight protein-tyrosine phosphatase [Text] / M. Kanda, Y. Ihara, H. Murata [et al.] // J. Biol. Chem. — 2006. — Vol. 281. — P. 28518–28528.

Regulation of stress-activated MAP kinase pathways during cell fate decisions [Text] / M. Takekawa, Y. Kubota, T. Nakamura, K. Ichikawa // Nagoya J. Med. Sci. — 2011. — Vol. 73, № 1–2. — P. 1–14.

Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure [Text] / T. Hamid, S. Z. Guo, J. R. Kingery [et al.] // Cardiovasc. Res. — 2011. — Vol. 89, № 1. — P. 129–138.

The NF kappa B-mediated control of RS and JNK signaling in vitamin A-treated cells: duration of JNK-AP-1 pathway activation may determine cell death or proliferation [Text] / A. Zanotto-Filho, D. P. Gelain, R. Schröder [et al.] // Biochem. Pharmacol. — 2009. — Vol. 77, № 7. — P. 1291–301.

Brownlee, M. Negative consequences of glycation [Text] / M. Brownlee // Metabolism. — 2000. — Vol. 49. — P. 9–13.

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE [Text] / M. P. Wautier, O. Chappey, S. Corda [et al.] // Am. J. Physiol. — 2001. — Vol. 280. — P. E685–694.

Forbes, J. M. Oxidative stress as a major culprit in kidney disease in diabetes [Text] / J. M. Forbes, M. T. Coughlan, M. E. Cooper // Diabetes — 2008. — Vol. 57. — P. 1446–1454.

Khan, Z. A. Cellular signalling and potential new treatment targets in diabetic retinopathy [Text] / Z. A. Khan, S. Chakrabarti // Exp. Diab. Res. — 2007. — Vol. 2007, Article ID 31867. — 12 p.

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase [Text] / T. J. Guzik, S. Mussa, D. Gastaldi [et al.] // Circulation. — 2002. — Vol. 105, № 14. — P. 1656–1662.

Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. [Text] / Y. Aliciguzel, I. Ozen, M. Aslan, U. Karayalcin // J. Lab. Clin. Med. — 2003. — Vol. 142. — P. 172–177.

Taniyama, Y. Reactive oxygen species in the vasculature: molecular and cellular mechanisms [Text] / Y. Taniyama, K. K. Griendling // Hypertension. — 2003. — Vol. 42, № 6. — P. 1075–1081.

Endemann, D. H. Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus [Text] / D. H. Endemann, E. L. Schiffrin // Curr. Hypertens. Rep. — 2004. — Vol. 6, № 2. — P. 85–89.

Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity [Text] / P. Newsholme, E. P. Haber, S. M. Hirabara [et al.] // J. Physiol. — 2007. — Vol. 583, Pt. 1. — P. 9–24.

Sivitz, W. I. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities [Text] / W. I. Sivitz, M. A. Yorek // Antiox. Redox. Signal. — 2010. — Vol. 12, № 4. — P. 537–577.

Peroxynitrite inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles [Text] / Y. Liu, K. Terata, Q. Chai [et al.] // Circ. Res. — 2002. — Vol. 91. — P. 1070–1076.

Soriano, F. G. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation [Text] / F. G. Soriano, L. Virag, C. Szabo // J. Mol. Med. — 2001. — Vol. 79. — P. 437–448.

Maritim, A. C. Diabetes, oxidative stress, and antioxidants: A review [Text] / A. C. Maritim, R. A. Sanders, J. B. Watkins, 3rd // J. Biochem. Mol. Toxicol. — 2003. — Vol. 17. — P. 24–38.

Abdul-Ghani, M. A. Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus [Text] / M. A. Abdul-Ghani, R. A. DeFronzo // Curr. Diabetis. Rep. — 2008. — Vol. 8. — P. 173–178.

Nitrosative stress and pathogenesis of insulin resistance [Text] / M. Kaneki, N. Shimizu, D. Yamada, K. Chang // Antioxid. Redox. Signal. — 2007. — Vol. 9. — P. 319–329.

Maiese, K. Mechanistic insights into diabetes mellitus and oxidative stress [Text] / K. Maiese, Z. Z. Chong, Y. C. Shang // Curr. Med. Chem. — 2007. — Vol. 14, № 16. — P. 1729–1738.

Maiese, K. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus [Text] / K. Maiese, S. D. Morhan, Z. Z. Chong // Curr. Neurovasc. Res. — 2007. — Vol. 4, № 1. — P. 63–71.

Averill, M. M. Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes [Text] / M. M. Averill, K. E. Bornfeldt // Curr. Diab. Rep. — 2009. — Vol. 9, № 1. — P. 18–25.

Oxidative stress and mitochondrial dysfunction in type 2 diabetes [Text] / V. M. Victor, M. Rocha, R. Herance, A. Hernandez-Mijares // Curr. Pharm. Des. — 2011. — Vol. 17, № 36. — P. 3947–58.

Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling [Text] / Y. Le Marchand-Brustel, P. Gual, T. Gremeaux [et al.] // Biochem. Soc. Trans. — 2003. — Vol. 31. —

P. 1152–1156.

Beta-cell glucose toxicity, lipotocicity, and chronic oxidative stress in type 2 diabetes [Text] / P. R. Robertson, J. Harmon, P. O. Tran, V. Poitout // Diabetes. — 2004. — Vol. 53, Suppl. 1. — P. S119-S124.

Pancreatic islets under attack: cellular and molecular effectors [Text] / M. Pearl-Yafe, A. Kaminitz, E. S. Yolcu [et al.] // Curr. Pharm. Des. — 2007. — Vol. 13. — P. 749–760.

Melloul, D. Role of NF-kappaB in beta-cell death [Text] / D. Melloul // Biochem. Soc. Trans. — 2008. — Vol. 36, Pt. 3. — P. 334–339.

Wajchenberg, B. L. Beta-cell failure in diabetes and preservation by clinical treatment [Text] / B. L. Wajchenberg // Endocrinol. Rev. — 2007. — Vol. 28. — P. 187–218.

Inflammation, oxidative stress, and obesity [Text] / A. Fernández-Sánchez, E. Madrigal-Santillán, M. Bautista [et al.] // Int. J. Mol. Sci. — 2011. — Vol. 12, № 5. — P. 3117–3132.

Khan, N. Obesity: An independent risk factor systemic oxidative stress [Text] / N. Khan, L. Naz, G. Yasmeen // Park. J. Pharm. Sci. — 2006. — Vol. 19. — P. 62–69.

Adipokines in inflammation and metabolic disease [Text] / N. Ouchi, J. L. Parker, J. J. Lugus, K. Walsh // Nat. Rev. Immunol. — 2011. —

Vol. 11. — P. 85–97.

Adipose tissue: the new endocrine organ? A review article [Text] / S. E. Wozniak, L. L. Gee, M. S. Wachtel, E. E. Frezza // Dig. Dis. Sci. — 2009. — Vol. 54, № 9. — P. 1847–1856.

Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome [Text] / Y. Jang, J. H. Lee, Y. Wang, G. Sweeney // Clin. Exp. Pharmacol. Physiol. — 2012. — Vol. 39, № 2. — P. 194–199.

Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis [Text] / R. Mogelvang, S. H. Pedersen, A. Flyvbjerg [et al.] // Am. J. Cardiol. — 2012. — Vol. 109, № 4. — P. 515–520.

Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue [Text] / B. S. Youn, S. I. Bang, N. Klöting [et al.] // Diabetes. — 2009. — Vol. 58, № 3. — P. 627–636.

PGRN is a key adipokine mediating high fat dietinduced insulin resistance and obesity through IL-6 in adipose tissue [Text] / T. Matsubara, A. Mita, K. Minami [et al.] // Cell. Metabol. — 2012. — Vol. 15, № 1. — P. 38–50.

Fetuin-A and incident diabetes mellitus in older persons: The Health Aging and Body Composition (Health ABC) Study [Text] / J. H. Ix, C. Wassel-Fyr, A. Kanaya [et al.] // JAMA. — 2008. — Vol. 300, № 2. — P. 182–188.

Mori, K. Fetuin-A and the cardiovascular system [Text] / K. Mori, M. Emoto, M. Inaba // Adv. Clin. Chem. — 2012. — Vol. 56. — P. 175–195.

Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man [Text] / D. R. Matthews, J. P. Hosker, A. S. Rudenski [et al.] // Diabetologia. — 1985. — Vol. 28. — P. 412–419.

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans [Text] / A. Katz, S. S. Nambi, K. Mather [et al.] // J. Clin. Endocrinol. Metabol. — 2000. — Vol. 85. — P. 2402–2410.

Resistin: functional roles and therapeutic considerations for cardiovascular disease [Text] / M. S. Jamaluddin, S. M. Weakley, Q. Yao, C. Chen // Br. J. Pharmacol. — 2012. — Vol. 165, № 3. — P. 622–632.

St-Pierre, Y. Emerging features in the regulation of MMP-9 gene expression for the development of novel molecular targets and therapeutic strategies [Text] / Y. St-Pierre, C. Van Themsche, P. O. Estève // Current drug targets. Inflammation and allergy. — 2003. — Vol. 2, № 3. — P. 206–215.

Downloads

Published

2012-10-10

How to Cite

Gorshunska, M. (2012). OXIDATIVE STERSS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RELATION TO CHARACTERISTICS OF THE DEVELOPMENT, PROGRESSION AND COMPLICATIONS (Review and our own results). Problems of Endocrine Pathology, 41(3), 113-124. https://doi.org/10.21856/j-PEP.2012.3.16

Most read articles by the same author(s)

1 2 > >>